Please ensure Javascript is enabled for purposes of website accessibility
OnCore Login

Return to Trial Database

HCRN-GU00-9

A Multicenter Randomized Phase II Study of Docetaxel plus Vinorelbine and Doxetacel plus Estramustine in Combination for Hormone Refractory Prostate Cancer

Status

Study Completed

Cancer Type(s)

Prostate

Study Contact

Publications

  • NM Hahn, W Fisher, R Langdon, R Zon, M Browning, C Calley, CJ Sweeney
Randomized Phase II Study of Docetaxel, Vinorelbine, and Estramustine in Combination in Hormone-Refractory Prostate Cancer with Pharmacogenetic Survival Analysis
  • NM Hahn, S Marsh, W Fisher, R Langdon, R Zon, M Browning, CS Johnson, TJ Scott-Horton, L Li, HL McLeod, CJ Sweeney

Trial Locations

All sites in which the trial HCRN-GU00-9 being conducted in.
No data was found